| Pharmacology of indole and indazole synthetic cannabinoid designer drugs ab-fubinaca, adb-fubinaca, ab-pinaca, adb-pinaca, 5f-ab-pinaca, 5f-adb-pinaca, adbica, and 5f-adbica SD Banister, M Moir, J Stuart, RC Kevin, KE Wood, M Longworth, ... ACS chemical neuroscience 6 (9), 1546-1559, 2015 | 243 | 2015 |
| Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135 SD Banister, J Stuart, RC Kevin, A Edington, M Longworth, SM Wilkinson, ... ACS Chemical Neuroscience 6 (8), 1445-1458, 2015 | 222 | 2015 |
| Engineered immune cells as highly sensitive cancer diagnostics A Aalipour, HY Chuang, S Murty, AL D’Souza, S Park, GS Gulati, CB Patel, ... Nature biotechnology 37 (5), 531-539, 2019 | 129 | 2019 |
| Design, Synthesis, and Structure−Affinity Relationships of Regioisomeric N-Benzyl Alkyl Ether Piperazine Derivatives as σ-1 Receptor Ligands IA Moussa, SD Banister, C Beinat, N Giboureau, AJ Reynolds, M Kassiou Journal of medicinal chemistry 53 (16), 6228-6239, 2010 | 96 | 2010 |
| The Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor (α7 nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia C Beinat, SD Banister, M Herrera, V Law, M Kassiou CNS drugs 29, 529-542, 2015 | 79 | 2015 |
| Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model S Murty, ST Haile, C Beinat, A Aalipour, IS Alam, T Murty, TM Shaffer, ... Oncoimmunology 9 (1), 1757360, 2020 | 63 | 2020 |
| Development and preclinical validation of a cysteine knottin peptide targeting integrin αvβ6 for near-infrared fluorescent-guided surgery in pancreatic cancer WS Tummers, RH Kimura, L Abou-Elkacem, C Beinat, AL Vahrmeijer, ... Clinical Cancer Research 24 (7), 1667-1676, 2018 | 52 | 2018 |
| PET reporter gene imaging and ganciclovir-mediated ablation of chimeric antigen receptor T cells in solid tumors S Murty, L Labanieh, T Murty, G Gowrishankar, T Haywood, IS Alam, ... Cancer Research 80 (21), 4731-4740, 2020 | 38 | 2020 |
| Insights into structure-activity relationships and CNS therapeutic applications of NR2B selective antagonists C Beinat, S Banister, I Moussa, A J Reynolds, C SP McErlean, M Kassiou Current medicinal chemistry 17 (34), 4166-4190, 2010 | 37 | 2010 |
| Positron emission tomography reporter gene strategy for use in the central nervous system T Haywood, C Beinat, G Gowrishankar, CB Patel, IS Alam, S Murty, ... Proceedings of the National Academy of Sciences 116 (23), 11402-11407, 2019 | 34 | 2019 |
| Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues SD Banister, J Stuart, T Conroy, M Longworth, M Manohar, C Beinat, ... Forensic Toxicology 33, 355-366, 2015 | 33 | 2015 |
| Structure–activity relationships of N-substituted 4-(trifluoromethoxy) benzamidines with affinity for GluN2B-containing NMDA receptors C Beinat, SD Banister, J Hoban, J Tsanaktsidis, A Metaxas, AD Windhorst, ... Bioorganic & Medicinal Chemistry Letters 24 (3), 828-830, 2014 | 29 | 2014 |
| Ultra-high-frequency radio-frequency acoustic molecular imaging with saline nanodroplets in living subjects YS Chen, Y Zhao, C Beinat, A Zlitni, EC Hsu, DH Chen, F Achterberg, ... Nature nanotechnology 16 (6), 717-724, 2021 | 26 | 2021 |
| Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands SD Banister, IA Moussa, C Beinat, AJ Reynolds, P Schiavini, ... Bioorganic & medicinal chemistry letters 21 (1), 38-41, 2011 | 25 | 2011 |
| Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [18F] DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression CB Patel, C Beinat, Y Xie, E Chang, SS Gambhir Neoplasia 23 (1), 58-67, 2021 | 20 | 2021 |
| Structure–activity relationship studies of SEN12333 analogues: determination of the optimal requirements for binding affinities at α7 nAChRs through incorporation of known … C Beinat, T Reekie, SD Banister, J O'Brien-Brown, T Xie, TT Olson, Y Xiao, ... European Journal of Medicinal Chemistry 95, 277-301, 2015 | 19 | 2015 |
| Development of [18F]DASA-23 for Imaging Tumor Glycolysis Through Noninvasive Measurement of Pyruvate Kinase M2 C Beinat, IS Alam, ML James, A Srinivasan, SS Gambhir Molecular imaging and biology 19, 665-672, 2017 | 18 | 2017 |
| Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [18F]DASA-23 C Beinat, CB Patel, Y Xie, SS Gambhir Molecular imaging and biology 22, 124-133, 2020 | 16 | 2020 |
| Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO) SD Banister, C Beinat, SM Wilkinson, B Shen, C Bartoli, S Selleri, ... European Journal of Medicinal Chemistry 93, 392-400, 2015 | 15 | 2015 |
| Human biodistribution and radiation dosimetry of [18F]DASA-23, a PET probe targeting pyruvate kinase M2 C Beinat, CB Patel, T Haywood, B Shen, L Naya, H Gandhi, D Holley, ... European journal of nuclear medicine and molecular imaging 47, 2123-2130, 2020 | 14 | 2020 |
